NDC 63323-617-01 - Milrinone Lactate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-617
- Requested NDC
- 63323-617-01
- Package NDCs from labels
- 63323-617-01, 63323-617-10, 63323-617-50, 63323-617-02, 63323-617-20
- Manufacturer
- Fresenius Kabi USA, LLC | HuZhou ZhanWang Pharmaceutical Co., Ltd
- Effective date
- 2023-03-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MILRINONE - Fresenius Kabi USA, LLC | HuZhou ZhanWang Pharmaceutical Co., Ltd | Fresenius Kabi USA, LLC | HuZhou ZhanWang Pharmaceutical Co., Ltd | 2023-03-17 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-617-01 | Milrinone Lactate | 10 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 10 | 6 | |
| 63323-617-02 | Milrinone Lactate | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 20 | 6 | |
| 63323-617-10 | Milrinone Lactate | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | 6 | |
| 63323-617-20 | Milrinone Lactate | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | 6 | |
| 63323-617-50 | Milrinone Lactate | 50 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 50 | 6 | |
| 63323-617-50 | Milrinone Lactate | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-617-01 | ML - Milliliter | 63323-617 | 0164d2fb-de7f-4c87-b54e-11fc54147a5c | 1 | 2025-10-14 |
| 63323-617-02 | ML - Milliliter | 63323-617 | c6fd8e0d-3eb0-4bee-9750-5b5ba37ca758 | 1 | 2025-07-08 |
| 63323-617-10 | ML - Milliliter | 63323-617 | 12c104a6-1d54-406c-8c8c-3fdc9afb4b68 | 1 | 2013-02-13 |
| 63323-617-20 | ML - Milliliter | 63323-617 | a4d179e4-e0ad-4534-875a-9cc80d9f3e87 | 1 | 2013-02-13 |
| 63323-617-50 | ML - Milliliter | 63323-617 | a67f1b90-71ee-4f8f-b4eb-e491aee4bdf4 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| MILRINONE LACTATE | ACTIVE INGREDIENT | 9K8XR81MO8 | MILRINONE LACTATE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| MILRINONE | ACTIVE MOIETY | JU9YAX04C7 | MILRINONE LACTATE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| ANHYDROUS DEXTROSE | INACTIVE INGREDIENT | 5SL0G7R0OK | MILRINONE LACTATE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| LACTIC ACID | INACTIVE INGREDIENT | 33X04XA5AT | MILRINONE LACTATE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | MILRINONE LACTATE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Circulation | CACTUS GRANDIFLORUS, KALI CARBONICUM, KALMIA LATIFOLIA, ARNICA MONTANA, GLONOINUM, IGNATIA AMARA, LACTICUM ACIDUM, RANUNCULUS BULBOSUS, ALPHA-KETOGLUTARICUM ACIDUM, ARSENICUM ALBUM, FUMARICUM ACIDUM, HEART (SUIS), HEPAR SUIS, MALICUM ACIDUM, NATRUM OXALACETICUM, PHOSPHORUS, STROPHANTHUS HISPIDUS, SPIGELIA ANTHELMIA, CARBO VEGETABILIS, NAJA TRIPUDIANS, CYTOMEGALOVIRUS NOSODE, EPSTEIN-BARR VIRUS NOSODE | Deseret Biologicals, Inc. | 29f30a6a-406d-4fb4-850d-d33486fbafe4 | 2024-04-18 | Warnings | 33X04XA5AT |
| Milrinone Lactate | MILRINONE LACTATE | Hikma Pharmaceuticals USA Inc. | b3c936b3-5c86-4d87-9544-e94e95d0245f | 2023-11-20 | Warnings, Adverse reactions | 1791859 1791854 9K8XR81MO8 |
| AnubisMed | GLYCOLIC ACID, CITRIC ACID, LACTIC ACID, KOJIC ACID | ANUBIS COSMETICS SL | eca95dde-cb57-2ab6-e053-2995a90af84f | 2023-09-05 | Warnings | 33X04XA5AT |
| Anubis Barcelona New Even | LACTIC ACID, CITRIC ACID, GLYCOLIC ACID | ANUBIS COSMETICS SL | eaeeb6e0-5322-20c4-e053-2995a90a9fd9 | 2023-09-01 | Warnings | 33X04XA5AT |
| Pancreapar | SYZYGIUM JAMBOLANUM, GLANDULA SUPRARENALIS SUIS, HYDRASTIS CANADENSIS, HYPOPHYSIS SUIS, PANCREAS SUIS, PHASEOLUS, ACETICUM ACIDUM, LACTICUM ACIDUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, URANIUM NITRICUM | Energique, Inc. | ba9c13d0-92de-4159-8a35-215e3de50c07 | 2023-08-24 | Warnings | 33X04XA5AT |
| Milrinone Lactate | MILRINONE LACTATE | Armas Pharmaceuticals Inc. | fde1e354-4f15-4ade-9ae3-db2ba67e0431 | 2023-04-05 | Warnings, Adverse reactions | 1791861 1791859 1791854 9K8XR81MO8 |
| Milrinone Lactate | MILRINONE LACTATE | Fresenius Kabi USA, LLC | ac43ba6b-635d-4129-8eea-96f3f5a4785e | 2023-03-17 | Warnings, Adverse reactions | ANDA075936 63323-617-10 63323-617-20 63323-617-02 63323-617-01 63323-617-50 63323-617 63323061701 1791861 1791859 1791854 7ada1876-c47a-4e3e-bd48-a6a1f486b517 ac43ba6b-635d-4129-8eea-96f3f5a4785e 9K8XR81MO8 |
| Milrinone Lactate | MILRINONE LACTATE IN 5% DEXTROSE | Eugia US LLC | 4e489fab-75bc-4514-9bf2-85b8ed08a1b0 | 2023-02-01 | Warnings, Adverse reactions | 9K8XR81MO8 |
| Milrinone Lactate | MILRINONE LACTATE | Somerset Therapeutics, LLC | ce43e850-4e80-4c5b-8811-9cb65824768c | 2022-09-23 | Warnings, Adverse reactions | 1791861 1791859 1791854 9K8XR81MO8 |
| Milrinone Lactate in Dextrose | MILRINONE LACTATE IN DEXTROSE | Hospira, Inc. | 5273ea17-6920-4bff-8c5b-20ea531a0423 | 2022-03-28 | Warnings, Adverse reactions | 9K8XR81MO8 |
| Milrinone Lactate | MILRINONE LACTATE | Meitheal Pharmaceuticals Inc. | 6c6b69f9-e229-4a93-a108-9eafdab614f0 | 2022-01-13 | Warnings, Adverse reactions | 1791861 1791859 1791854 9K8XR81MO8 |
| Milrinone Lactate in Dextrose | MILRINONE LACTATE | Gland Pharma Limited | 838da14b-c070-4c09-b088-99e7c64d9964 | 2021-08-25 | Warnings, Adverse reactions | 9K8XR81MO8 |
| Milrinone Lactate in Dextrose | MILRINONE LACTATE | Sagent Pharmaceuticals | bb0157d0-a414-43fa-81e0-8c92d717f1b2 | 2020-11-20 | Warnings, Adverse reactions | 9K8XR81MO8 |
| OMEOSPORT | .ALPHA.-KETOGLUTARIC ACID - ACONITIC ACID, CIS - ADENOSINE TRIPHOSPHATE - ALPHA LIPOIC ACID - ASCORBIC ACID - ASIAN GINSENG - BARIUM CATION - BEET - CEROUS OXALATE NONAHYDRATE - COENZYME A - CYSTEINE - FUMARIC ACID - LACTIC ACID, DL - MAGNESIUM CARBONATE - MALIC ACID - MANGANESE PHOSPHATE, DIBASIC - PORK - PYRIDOXINE HYDROCHLORIDE - RIBOFLAVIN - SODIUM DIETHYL OXALACETATE - SODIUM PYRUVATE - SUCCINIC ACID - SUS SCROFA ADRENAL GLAND - THIAMINE HYDROCHLORIDE - SUS SCROFA EMBRYO - | Guna spa | 119a205d-0074-48ff-ac78-e2300db45227 | 2018-12-21 | Warnings | 33X04XA5AT |
| Milrinone Lactate | MILRINONE LACTATE | Hikma Pharmaceuticals USA Inc. | bb7500f8-dbfd-4c8a-ac2e-5533609c3970 | 2018-06-01 | Warnings, Adverse reactions | 1791859 9K8XR81MO8 |
| Milrinone Lactate in Dextrose | MILRINONE LACTATE | Baxter Healthcare Corporation | 8fd0f93a-6150-4020-b7ee-4b95b520f6ce | 2018-05-30 | Warnings, Adverse reactions | 9K8XR81MO8 |
| Glucose Control T015 | SYZYGIUM JAMBOLANUM, GLANDULA SUPRARENALIS SUIS, HYDRASTIS CANADENSIS, HYPOPHYSIS SUIS, PANCREAS SUIS, PHASEOLUS, ACETICUM ACIDUM, LACTICUM ACIDUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, URANIUM NITRICUM | Guangzhou Renuma Medical Systems Co., Ltd | 3fd02c0a-5cf1-4f35-86d0-d5d09e63f39b | 2017-10-26 | Warnings | 33X04XA5AT |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.